Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities

Colaboración

Año: 2022

Causa, R; Almagro-Nievas, D; Rivera-Izquierdo, M; Benitez-Munoz, N; Lopez-Hernandez, B; Garcia-Garcia, F; Alvarez-Estevez, M; Soto-Perez, MD; Bermudez-Tamayo, C

Título: GERONTOLOGY

• Q2